SCHEMBL4083594

SCHEMBL4083594

CN1C(=O)NC(C2C3CC4CC2CC(O)(C4)C3)C1(C)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 17/20 0.39
ALDH1A1 P00352 1/20 0.34
CTSD P07339 1/20 0.33
BACE1 P56817 1/20 0.33
BACE2 Q9Y5Z0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4082619 0.89 HSD11B1 (0.41) HSD11B1
SCHEMBL4079059 0.84 HSD11B1 (0.37) HSD11B1
SCHEMBL4078946 0.84 HSD11B1 (0.42) HSD11B1ALDH1A1
SCHEMBL4084575 0.80 HSD11B1 (0.41) HSD11B1
SCHEMBL4089619 0.76 HSD11B1 (0.36) HSD11B1
SCHEMBL4088781 0.76 HSD11B1 (0.36) HSD11B1
SCHEMBL75774 0.70 HSD11B1 (0.48) HSD11B1
SCHEMBL4083372 0.69 HSD11B1 (0.34) HSD11B1
SCHEMBL4088853 0.69 HSD11B1 (0.36) HSD11B1
SCHEMBL4089217 0.69 HSD11B1 (0.33) HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2104665-A2 IMIDAZOLONE AND IMIDAZOLIDINONE DERIVATIVES AS 11B-HSD1 INHIBITORS FOR DIABETES F. Hoffmann-Roche AG (CH) 2009-09-30 EP claimed
WO-2008046758-A2 IMIDAZOLONE AND IMIDAZOLIDINONE DERIVATIVES AS 11B-HSD1 INHIBITORS FOR DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2008-04-24 WO claimed
EP-2104665-A2 IMIDAZOLONE AND IMIDAZOLIDINONE DERIVATIVES AS 11B-HSD1 INHIBITORS FOR DIABETES F. Hoffmann-Roche AG (CH) 2009-09-30 EP disclosed
WO-2008046758-A2 IMIDAZOLONE AND IMIDAZOLIDINONE DERIVATIVES AS 11B-HSD1 INHIBITORS FOR DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2008-04-24 WO disclosed